Europe
SenzaGen announced today that the company will launch GARDair, the first in vitro test for airway allergies at ESTIV2018, the 20th International Congress on In Vitro Toxicology.
Supported by two clusters with a focus on digital and medical activities and backed by industry groups and over 45 innovative companies, the Hu-PreciMED project will gear the French precision medicine industry towards discovering new diagnostic approaches and novel therapeutic treatments more rapidly
Joint R&D work aims at microbial strain development for the production of high-value chemicals including bioplastics
A recent survey by the Pew Research Center found that 57 percent of Americans surveyed thought it was appropriate to use genetically engineered animals to grow organs for human transplants.
A second former GlaxoSmithKline scientist has pled guilty to stealing trade secrets as part of a scheme to benefit a startup China-based pharmaceutical company he helped establish.
Novo Nordisk is laying off 400 staffers so it can shift funds toward biological and technological innovation.
Investment in new lab will support integrated optimisation of upstream and downstream process development
C201 phase 2 will study immuno-enhancer antibody GM102, targeting AMHRII as a single agent and in combination with Trifluridine/Tipiracil (Lonsurf®)
The US-based aviation maintenance, repair and overhaul (MRO) and manufacturing organisation will adopt Q-Pulse FAIR to help with contracts relating to Airframe OEM’s
Medtronic CEO Omar Ishrak Commits to Continue Accelerating Diversity, Inclusion and Gender Equality
PRESS RELEASES